[Facial mucormycosis: observations from three cases].
The mucormycosis is a rare opportunistic invasive infection caused by fungi of the order Mucorales and characterized by vascular invasion and tissue necrosis. It affects generally the subjects with altered natural resistances, particularly the diabetics patients. The cerebro-rhino-orbital region is the most common site. The clinical signs depend on the intra-tissular and intra-vascular evolution of the fungi. The diagnosis of this disease is asserted by the mycological and anatomo-pathological exams. The treatment is based on the antifungic and the surgical excision of necrotic tissues. We report three observations: one man (42 years) and two women (59 and 60 years). Diabetes was found in two cases. The diagnosis was in every case anatomo-pathologic. Our objective was to study the epidemiological and clinico-pathologic aspects of this serious affection and to discuss its prognosis.
Sellami-Boudawara
T
T
Laboratoire d'Anatomie et de Cytologie Pathologique, EPS, Habib Bourguiba de Sfax.
Gouiaa
N
N
Charfeddine
I
I
Abdelmoula
M
M
Drira
M
M
Jlidi
R
R
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003881:Dermatomycoses / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology*; D048909:Diabetes Complications; D005145:Face / Q000382:microbiology / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology*; D009668:Nose Diseases / Q000150:complications / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D009916:Orbital Diseases / Q000150:complications / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D011379:Prognosis
D000935:Antifungal Agents; D000666:Amphotericin B